the reduction was more than half in patients with acute and chronic myelogenous leukemia and immunoblastoma , it was only one quarter in patients with chronic lymphocytic leukemia , hodgkin 's disease and lymphosarcoma .
C0019829
hodgkin 's
C0024299
lymphosarcoma